Background: Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of
chronic liver disease worldwide, directly related to the progressive increase in body weight …

Non-alcoholic fatty liver disease (NAFLD) is regarded as one of the most common liver
pathologies in many societies. Resveratrol, as a phenolic compound with powerful …

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease with
rising prevalence. Increasing evidence has demonstrated that resveratrol, a dietary …

Objective “The obesity epidemic” has led to an increase in obesity-related conditions
including non-alcoholic fatty liver disease (NAFLD), for which effective treatments are in …

Background: Resveratrol, a polyphenol found in various plants, is known for its diverse
bioactivities and has been explored in relation to nonalcoholic fatty liver disease (NAFLD) …

Many studies have shown that resveratrol has a lot of therapeutic effects on liver disorders.
Its administration can significantly increase the survival rate after liver transplantation …

Nonalcoholic fatty liver disease (NAFLD) is considered to be one of the most common liver
pathologies that occur widely among societies with a predominance of the Western dietary …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the
world. Resveratrol is a polyphenolic compound with antioxidant capacity that shows …

Purpose: Despite a proposed role for oxidative stress in the pathogenesis of nonalcoholic
fatty liver disease (NAFLD), antioxidant approaches have not been sufficiently investigated …

Background: Resveratrol is a potential treatment option for management of non-alcoholic
fatty liver disease (NAFLD) due to its anti-inflammatory, antioxidant properties, and calorie …